Recently, the aberrant expression of PCDHGA9 has been reported in some cancers with unfavorable prognosis, such as acute lymphoblastic leukemia, nasopharyngeal carcinoma, and astrocytoma11–13. This evidence concerns the gene PCDHGA9 and nasopharyngeal carcinoma.